Literature DB >> 22913307

The incidence of maxillary sinus membrane perforation during endoscopically assessed crestal sinus floor elevation: a pilot study.

Antoanela Garbacea1, Jaime L Lozada, Christopher A Church, Aladdin J Al-Ardah, Kristin A Seiberling, W Patrick Naylor, Jung-Wei Chen.   

Abstract

Transcrestal sinus membrane elevation is a surgical procedure performed to increase the bone volume in the maxillary sinus cavity. Because of visual limitations, the potential for maxillary sinus membrane perforations may be greater than with the lateral approach technique. The aim of this study was to macroscopically investigate ex vivo the occurrence of sinus membrane perforation during surgery using 3 transcrestal sinus floor elevation methods. Twenty fresh human cadaver heads, with 40 intact sinuses, were used for simultaneous sinus membrane elevation, placement of graft material, and dental implants. Real-time sinus endoscopy, periapical digital radiographs, and cone-beam computerized tomography (CBCT) images were subsequently used to evaluate the outcome of each surgical procedure. Perforation rates for each of the 3 techniques were then compared using a significance level of P < .05. No statistically significant differences in the perforation rate (P = .79) were found among the 3 surgical techniques. Although the sinus endoscope noted a higher frequency of perforations at the time of implant placement as compared with instrumentation or graft insertion, the difference was not statistically significant (P = .04). The CBCT readings were judged to be more accurate for identifying evidence of sinus perforations than the periapical radiographs when compared with the direct visualization with the endoscope. This pilot study demonstrated that a sinus membrane perforation can occur at any time during the sinus lift procedure, independent of the surgical method used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913307     DOI: 10.1563/AAID-JOI-D-12-00083

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  7 in total

1.  Ex vivo comparative study on three sinus lift tools for transcrestal detaching maxillary sinus mucosa.

Authors:  Yanfeng Li; Pin Hu; Yishi Han; Jiadong Fan; Xinming Dong; Huan Ren; Chunhao Yang; Tingting Shi; Dong Xia
Journal:  Bioengineered       Date:  2016-10-28       Impact factor: 3.269

2.  Evaluation of crestal sinus floor elevations using versah burs with simultaneous implant placement, at residual bone height ≥ 2.0 _ < 6.0 mm. A prospective clinical study.

Authors:  Jenna Z Alhayati; Auday M Al-Anee
Journal:  Oral Maxillofac Surg       Date:  2022-05-14

3.  Stress distribution of various designs of prostheses on short implants or standard implants in posterior maxilla: a three dimensional finite element analysis.

Authors:  K Jomjunyong; P Rungsiyakull; C Rungsiyakull; W Aunmeungtong; M Chantaramungkorn; P Khongkhunthian
Journal:  Oral Implantol (Rome)       Date:  2017-01-21

Review 4.  Clinical and biological analysis in graftless maxillary sinus lift.

Authors:  Marcelo Parra; Sergio Olate; Mario Cantín
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-08-24

5.  Patient's perception of recovery after osteotome-mediated sinus floor elevation with Bio-Oss collagen compared with no grafting material: a randomized single-blinded controlled trial.

Authors:  Thomas Starch-Jensen; Niels Henrik Bruun
Journal:  Int J Implant Dent       Date:  2021-03-22

6.  Intraoperative complications and early implant failure after transcrestal sinus floor elevation with residual bone height ≤5 mm: A retrospective multicenter study.

Authors:  Claudio Stacchi; Fabio Bernardello; Sergio Spinato; Rossano Mura; Michele Perelli; Teresa Lombardi; Giuseppe Troiano; Luigi Canullo
Journal:  Clin Oral Implants Res       Date:  2022-05-29       Impact factor: 5.021

7.  Crestal endoscopic approach for evaluating sinus membrane elevation technique.

Authors:  Samy Elian; Khaled Barakat
Journal:  Int J Implant Dent       Date:  2018-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.